Objective: Penile metastases are late manifestations of a primary tumor, and they are a sign of poor prognosis. We report a case of a rare presentation: penile metastases from prostate cancer.
Methods: 77 year-old male presented hematuria and acute urinary retention; on physical examination multiple hard lesions were detected. The patient underwent a Doppler ultrasound, subsequent penile and prostate biopsy, and staging study. Currently he is being treated with complete androgen blockade.
Results: A histological study of the penile biopsy showed penile metastasis from prostate adenocarcinoma. The histological study of prostate biopsy confirmed Gleason 8 (4+4) adenocarcinoma.
Conclusions: Despite of the different therapeutic alternatives for treatment of symptomatic penile metastases, it would be with palliative target; due to the median survival of these patients is less than a year.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
An Unusual Presentation of Gastric Cancer Metastatic to the Penile Shaft and Perineum.
Cureus
November 2024
Radiation Oncology, Garnet Health, Middletown, USA.
Article Synopsis
- A 69-year-old Jamaican male with initially diagnosed gastric adenocarcinoma underwent standard treatment, including surgical resection and chemoradiation.
- Two years later, he experienced dyspareunia and was found to have penile skin changes, leading to a diagnosis of metastatic gastric cancer.
- After receiving chemotherapy and salvage radiotherapy, he was monitored for 15 months but eventually lost to follow-up and passed away.
Factor associated with postoperative complications of inguinal lymph node dissection for penile cancer Test.
Urol Ann
October 2024
Department of Surgery, Division of Urology, Phramongkutklao Hospital, Royal Thai Army, Bangkok, Thailand.
Background: Inguinal lymph node dissection (ILND) is the standard of care for palpable, biopsy-proven lymph node metastases or high-risk groups for nonpalpable lymph nodes in the treatment of penile cancer. ILND is associated with a significant incidence of complications and adverse events, specifically wound complications. Few studies have identified risk factors related to postoperative ILND complications.
View Article and Find Full Text PDFLate metastasis of rectal adenocarcinoma to the penis.
BMJ Case Rep
November 2024
Urology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Rectal cancer metastasising to the penis is an exceptionally rare clinical entity, with less than 80 reported cases. Metastasis to the penis is typically identified in conjunction with widespread metastatic disease and as such is usually associated with a very poor prognosis. We report a case of a man who presented with a metastatic deposit in his penis 15 years after the initial diagnosis of rectal cancer.
View Article and Find Full Text PDFPenile Metastasis-Induced Priapism as the First Sign of Lung Cancer: A Case Report and Review of the Literature.
Case Rep Urol
November 2024
Urology Department, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10 1200, Brussels, Belgium.
The penis is a relatively uncommon organ for metastases. Secondary lesions often originate from the bladder, prostate, or rectosigmoid cancers. Only a few cases have described penile lesions secondary to lung cancers, mostly as a later complication.
View Article and Find Full Text PDFTislelizumab plus chemotherapy in metastatic extramammary Paget disease after surgery: a case report.
Front Oncol
October 2024
Department of Urology, The 940t Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, Gansu, China.
Article Synopsis
- Extramammary Paget disease (EMPD) is a rare type of skin cancer that mainly affects areas with apocrine glands like the vulva, scrotum, and penis, and often has a poor prognosis, especially with distant metastases.
- Patients with localized EMPD generally have a good 5-year survival rate between 60%-92%, while those with metastases only have about a 10% survival rate.
- A case report highlights a 57-year-old man with metastatic EMPD who responded well to a combination of an immune checkpoint inhibitor and chemotherapy, suggesting this approach may improve outcomes for others with similar advanced disease.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!